Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call.
ACADIA Pharmaceuticals has an average outperform rating and a price target range of $12 to $39, according to analysts polled by Capital IQ.
Price: 30.49, Change: +4.69, Percent Change: +18.18
.
ACADIA Pharmaceuticals has an average rating of outperform and price targets ranging from $12 to $39, according to analysts polled by Capital IQ.
Price: 30.43, Change: +4.63, Percent Change:.